Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen (Q34545711)

2 August 2017

title

Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen (English)

1 reference

2 August 2017

1 reference

4

Geert Leroux-Roels

0 references

author name string

Isabelle Desombere

series ordinal

1

1 reference

2 August 2017

Annick Willems

series ordinal

2

1 reference

2 August 2017

Yvonne Gijbels

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

80

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

3506-3514

1 reference

Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Immunology of hepatitis B virus and hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Immunogenetics of the response to HBsAg vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Response to hepatitis B vaccine: multiple HLA genes are involved

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Computer-aided studies on the spatial structure of the small hepatitis B surface protein

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Proposition of a three-dimensional representation of the constitutive protein of the hepatitis B surface antigen particles

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Novel transmembrane topology of the hepatitis B virus envelope proteins.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

A topological model for hepatitis B surface antigen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Characterization of the HBsAg particle lipid membrane

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Development of a hepatitis B vaccine from transformed yeast cells.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1440404

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg

27 October 2018

1 reference

12 December 2020

Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels

1 reference

12 December 2020

The topology of the S protein in the yeast-derived hepatitis B surface antigen particles

1 reference

12 December 2020

Antigenicity of hepatitis B surface antigen proteins reconstituted with phospholipids

1 reference

12 December 2020

Accurate determination of adjuvant-associated protein or peptide by ninhydrin assay

1 reference

12 December 2020

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

1 reference

12 December 2020

Stability of the lipid and protein of hepatitis-associated (Australia) antigen

1 reference

12 December 2020

Hepatitis B polypeptide vaccine preparation in micelle form

1 reference

12 December 2020

10.1128/JVI.80.7.3506-3514.2006

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference